Results 91 to 100 of about 22,497,798 (252)

Nutrigenomics: The science of the 21st century [PDF]

, 2011
nem
Marković Danica, Stojanović Dušica
core   +1 more source

Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) Levels

Frontiers in Neurology, 2016
Lipoprotein(a) is a plasma lipoprotein and known cardiovascular risk factor most recently implicated in the development of high-risk carotid atherosclerotic plaques without significant carotid stenosis.
Zachary Bulwa, Audrey Kim, Karandeep Singh, Alexander Kantorovich, Faten Suhail   +4 more
doaj   +1 more source

Creixement tumoral i metabolisme de l'hoste: dues cares d'una mateixa moneda [PDF]

, 1993
L'etiologia del càncer es basa fonamentalment en l'aparició d'un dany genètic en una cèl·lula que ocasiona una expressió anormal de determinats gens, els productes dels quals canvien dramàticament el fenotip cel·lular.
Argilés Huguet, Josep Maria, Llovera, Marta, López Soriano, Francisco Javier   +2 more
core  

Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without

International Journal of General Medicine, 2023
Bingyan Yu,1,2,* Xiangming Hu,2,* Jieliang Liu,2 Zhiqiang Nie,3 Ci Ren Luo Bu,4 Guang Li,2 Yingling Zhou,2 Haojian Dong2,4 1School of Medicine, South China University of Technology, Guangzhou, People’s Republic of China; 2Department of Cardiology,
Yu B, Hu X, Liu J, Nie Z, Ren Luo Bu C, Li G, Zhou Y, Dong H   +7 more
doaj  

Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard

Journal of Lipid Research, 1999
LP[a] is one of the most atherogenic lipoproteins consisting of an LDL-like core particle and a covalently linked glycoprotein of variable size.
Gert M. Kostner, Anton Ibovnik, Herwig Holzer, Harald Grillhofer   +3 more
doaj  

Lipoprotein(a) and risk-weighted apolipoprotein B: a novel metric for atherogenic risk

Lipids in Health and Disease
Background Retention of apolipoprotein B (apoB)-containing lipoproteins within the arterial wall plays a major causal role in atherosclerotic cardiovascular disease (ASCVD). There is a single apoB molecule in all apoB-containing lipoproteins.
Michaela B. Rehman, Benoit V. Tudrej
doaj   +1 more source

High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients

Vascular Health and Risk Management, 2020
I Dewa Gde Dwi Sumarjaya,1 I Ketut Badjra Nadha,2 Anak Agung Wiradewi Lestari3 1Specialist Program of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia; 2Department of Cardiology and ...
Sumarjaya IDGD, Nadha IKB, Lestari AAW
doaj  

Porodična hiperkolesterolemija - mislimo li dovoljno o ovoj teškoj bolesti? [Familial hypercholesterolemia - do we think enough about this severe disease?] [PDF]

, 2013
Familial hypercholesterolemia is the most common genetic metabolic disorder and is associated with significant morbidity and mortality from cardiovascular disease, in particular coronary heart disease (CHD). Gene mutations for LDL receptor, APOB or PCSK9
Pećin, Ivan, Reiner, Željko, Šućur, Nediljko   +2 more
core  

Analysis of low-density lipoprotein in diabetic patients using the Martin/Hopkins and Sampson equationsReply. [PDF]

Arq Bras Cardiol, 2023
Nascimento CRD, Mendes R, Botelho Filho CAL, Barbosa RHA, Tenório PP.   +4 more
europepmc   +1 more source

Should lipoproteina be measured in the pediatric population?

Introduction. Atherosclerotic cardiovascular disease CVD, a leading cause of death globally, has origins in childhood. Lipoprotein a [Lpa] is associated with premature CVD, but its impact on cardiovascular health during childhood is less understood.
Eşanu, V., Eşanu, V., Pîrţu, L.I., Pirtsu, L., Revenco, N.E., Palii, I.   +5 more
openaire   +2 more sources